To prepare for your visit, you’ll receive an email from Datacapt. Subject line will be:

· If YOU are New to Datacapt: [SGS] Welcome to SGS’s Datacapt Platform!

· If YOU are Already Registered: [Study Number] – Informed Consent Paperwork

The email includes links to:

· Informed Consent

· Medical History (emailed after IC)

· Health & Eligibility (emailed after Medical History)

If it’s your first time, create a password using your email as your username.

Important: All forms must be completed before your appointment. Incomplete forms may lead to delays or rescheduling.

*******************************************************************************************

If you have the following AUTOIMMUNE DISEASES, you can not qualify for our studies.

Here's a list of autoimmune diseases:

• Alopecia areata: Immune system attacks hair follicles, causing hair loss. 
• Addison's disease: Destroys adrenal glands, affecting hormone production. 
• Autoimmune hepatitis: Immune system attacks liver cells. 
• Celiac disease: Immune response to gluten, causing damage to the small intestine. 
• Type 1 diabetes: Immune system attacks cells in the pancreas that produce insulin. 
• Graves' disease: Immune system attacks thyroid gland, causing hyperthyroidism. 
• Hashimoto's thyroiditis: Immune system attacks thyroid gland, causing hypothyroidism. 
• Inflammatory bowel disease (IBD): Affects the digestive tract, including Crohn's disease and ulcerative colitis. 
• Multiple sclerosis: Immune system attacks the brain and spinal cord, disrupting nerve function. 
• Myasthenia gravis: Immune system attacks nerve-muscle junctions, causing muscle weakness. 
• Pernicious anemia: Immune system attacks cells in the stomach that produce a protein needed for B12 absorption. 
• Rheumatoid arthritis: Immune system attacks joints, causing inflammation and pain. 
• Systemic lupus erythematosus (Lupus): Immune system attacks various organs and tissues. 
• Sjögren's syndrome: Immune system attacks glands that produce tears and saliva. 
• Vitiligo: Immune system attacks cells that produce pigment in the skin. 
• Psoriasis: Immune system causes skin cells to multiply too quickly, leading to scaly, inflamed skin. 
• Scleroderma: Immune system attacks connective tissues, causing hardening and damage to skin and other organs. 
• Dermatomyositis: Immune system attacks muscles and skin, causing inflammation. 
• Polymyositis: Immune system attacks muscles, causing weakness. 
• Behcet's disease: Immune system attacks blood vessels, causing inflammation. 
• Ankylosing spondylitis: Immune system attacks the spine and other joints, causing inflammation and stiffness. 
• Reactive arthritis: Immune system attacks joints after an infection. 

C25-D075- FACE SERUM

Break period: 30Days from any study.

C25-DH128 Anti-Aging

Study Description: This study is testing how well and how safely a new facial product works over a 12-week period. It’s designed for both men and women who show mild to moderate signs of facial aging—such as wrinkles, uneven skin texture, reduced firmness and elasticity, and dullness. The product will be applied to specific areas of the face, and researchers will monitor improvements in skin appearance and overall tolerance to the product.

Gender: Males only- open for Caucasian with Fair skin, Hispanic, and African American. 

Age: 25-65 y/o

Skin Types: Fitz I-VI

Compensation: Up to $500.00

Study Eligibility:

• Cannot have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as multiple sclerosis, Crohn's disease, HIV, or rheumatoid arthritis).
• Cannot have artificial eyelashes, jewelry that cannot be removed, or any kind of tattooed-on eyebrows or any permanent facial makeup.
• Must have wrinkles on face and vertical lines on the neck.
  

C25-D102 Facial Treatment

C25-D058 Facial Serum

C25-D153 Facial Treatment

Study Description:  This clinical trial is to test a  facial product when used over the course of 12 weeks by women with wrinkles on the forehead, glabella, and crow's feet area; lines on the neck; and uneven skin tone.

Gender: Female

Age: 30-65 years old for Caucasian, Hispanic, 

and 35 to 70 for Asian & African American female.

Compensation: Up to $475.00

Study Eligibility:

• Cannot have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as multiple sclerosis, Crohn's disease, HIV, or rheumatoid arthritis)

C25-D143 GLP-1 Break period: 4 weeks from face and/or neck 

Study Description: This clinical trial is to text a facial product over 12 weeks in women using GLP-1 medications for weight loss, who present with mild to moderate facial concerns including wrinkles (forehead, glabella, crow’s feet, marionette lines), and neck sagging

Gender: Female

Age: 35-65 years old

Skin Types: Fitz I-VI

Compensation: Up to $450.00

Study Eligibility:

• Cannot have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as lupus, Crohn's disease, HIV, or rheumatoid arthritis).
• Must be user of a GLP-1 medication for weight loss purposes.
• Avoid application of any topical moisturizing products to the face and neck for at least 3 days prior to visit 1.
• Bring documentation of GLP-1 medication use (prescription, image of product or package, purchase receipt, online order, etc.). The documentation and product label must be current and match your name.

C25-D121 Facial Treatment

Study Description: This clinical trial is designed to test the Sponsor's facial treatment over 12 weeks in women with mild to moderate signs of aging, including crow's feet and under-eye fine lines, reduced cheek softness (tactile), and visual concerns such as uneven texture, enlarged pores, mottled hyperpigmentation, and redness (limited to Fitzpatrick skin types I–III) on the global face.

Gender: Females  

No permanent face make up!

Age: 30-65 years old for Caucasian, or 30 up to 70 for African American

Skin Types: Fitz I-VI

Compensation: Up to $425.00

Study Eligibility:

• Cannot have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as multiple sclerosis, Crohn's disease, HIV, or rheumatoid arthritis).
• Cannot use topical moisturizing or treatment products on the face 3 days prior to first visit.
• Must have Fine Lines on crow’s feet area and under eye area, visual pores, redness on face(Fitz I-III), uneven skin tone on face, lack of softness on cheeks.

C25-D133 Facial Treatment

Study Description: This clinical trial is to test a facial product over 12 weeks in women with signs of aging, including crow's feet wrinkles, sagging in the cheeks and neck.

Gender: Females  No permanent face make up!

Age: 35-65 years old for Caucasian, Hispanic female 

(35 up to 70 years old for Asian & African American)

Skin Types: I-VI

Compensation: Up to $600.00

Study Eligibility:

• Cannot have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as multiple sclerosis, Crohn's disease, HIV, or rheumatoid arthritis).
• Cannot have artificial eyelashes or eyelash extensions
• Must be willing to give a saliva sample in clinic

 TEXT JOANNE 214-395-0600 

C25-D107 Facial SPF Sunscreen study

Study Description: This study is designed to evaluate how effective and well-tolerated the Sponsor’s facial skincare product is over an 8-week period. We’re looking for participants who have fine lines, uneven skin tone, dark spots (hyperpigmentation), or redness

Gender: Male and Females   

 No permanent face make up!

Age: 18–55-year-olds

Skin Types: Fitz I-VI

Compensation: Up to $400.00

Study Eligibility:

• Cannot have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as lupus, Crohn's disease, HIV, or rheumatoid arthritis).
• Bring your regularly used basic (without antiaging claims or ingredients) facial skin care products (cleansers/soaps, moisturizers, toners, and/or serums) and sunscreen (at least SPF 30) with a history of safe usage to your first visit for documentation.
• Avoid the use of any topical skin care products at least 2 days prior to first visit.

C25-D117 Facial Serum

Study Description: This clinical trial is to text a facial serum product when used over the course of 56 days by women with sagging on the cheeks; and uneven skin tone, redness (only those with Fitzpatrick skin types I-IV. [FM(1] 

Gender: Females  

 No permanent face make up!

Age: 20-50 years old

Skin Types: Fitz I-VI

Compensation: Up to $300.00

Study Eligibility:

• Cannot have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as multiple sclerosis, Crohn's disease, HIV, or rheumatoid arthritis).
• Cannot have nonremovable jewelry, artificial eyelashes and/or eyelash extensions
• Must be regular user of Sunscreen used at least 3 times a week

C25-D139 Retinol Serum

C25-D084 Grey Hair Serum

C25-D125 Anti-Aging

Study Description: This study is testing a facial skincare product over 8 weeks in adults who show early signs of aging. These signs may include:

• Fine lines on the face and chest area
• Uneven skin texture on the forehead and neck (both how it looks and feels)
• Less fullness or plumpness in areas like the forehead and cheeks
• Wrinkles in common areas such as:
• Forehead
• Between the eyebrows (glabella)
• Around the eyes (crow’s feet)
• Smile lines (nasolabial folds)
• Under the eyes
• Lines around the mouth (marionette lines)

People with sensitive skin may also be eligible to participate.

Gender: Male and Females  No permanent face make up!

Age: 35-55 years old for Caucasian, Hispanic, 

(35 up to 65 for Asian, Black or African American)

Skin Types: I-VI

Compensation: Up to $400.00

Study Eligibility:

• Cannot have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as multiple sclerosis, Crohn's disease, HIV, or rheumatoid arthritis).
• Men cannot have any facial hair and must be willing to shave within 24 hours of each visit.

• Must avoid use of topical moisturizing products to the face or decollete for 2 days prior to visit 1.

C25-D132 Facial Treatment

Study Description: This single-center cosmetic clinical trial evaluates the efficacy of the Sponsor’s facial treatment over 8 weeks in women with mild to moderate PIH/PIE and at least one target lesion on the face.

Gender: Females

Age: 25-65 years old for Hispanic, Caucasian 

(25 Up to 70 for African American and Asian)

Skin Types: Fitz I-VI

Compensation: Up to $300.00

Study Eligibility:

• Cannot have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as multiple sclerosis, Crohn's disease, HIV, or rheumatoid arthritis).
• Cannot have artificial eyelashes, eye lash extensions, and/or tattooed-on eyebrows or other permanent facial makeup.
• Must have visible acne marks.
• Must avoid application of any topical moisturizing or treatment products to the face at least 3 days prior to visit 1.